Mandatory Electronic Prescribing of Controlled Substances (EPCS) Can Help Combat the Opioid Crisis
April 04, 2018
According to government estimates, the opioid epidemic has reached crisis proportions, and now costs the US more than $500 billion...
Filter by:
Choose a Topic
Filter by Year:Clear Filters- Research
- Biosimilars
- Drug Abuse Prevention
- Drug Adherence Programs
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Employers, Unions, & Insurers
- FEHB Program
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Health Insurance Marketplace (ACA)
- Home Delivery of Drugs
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- REMS Management
- Specialty Benefit Design
- Specialty Pharmacies
- Specialty Pharmacy Networks
- TRICARE
PCMA Member Survey: The Impact of POS Rebates and POS Pharmacy DIR
March 27, 2018
The Pharmaceutical Care Management Association (PCMA) had an independent third party conduct a survey of its members to assess the...
Milliman Analysis: Medicare Part D Program Characteristics that Affect Plan Sponsor Gain/Loss Margin
March 16, 2018
The Medicare Part D program has regulatory requirements and competitive dynamics that affect plan sponsor gain/(loss) margin. The Pharmaceutical Care...
Increased Costs Associated With Proposed State Legislation Impacting PBM Tools
February 27, 2018
Visante was commissioned by the Pharmaceutical Care Management Association (PCMA) to estimate the potential cost impact of four types of...
Economic Impact of CMS’ Proposed Any Willing Pharmacy Policy
January 15, 2018
In its Notice of Proposed Rulemaking for 2019, the Centers for Medicare and Medicaid Services (CMS) has proposed what it...
Some Common Sense Solutions to the Opioid Crisis
November 07, 2017
The Pharmaceutical Care Management Association (PCMA) has outlined solutions that would help assure people receive opioid prescriptions only when medically...
October 17, 2017
Read PCMA’s testimony before the U.S. Senate Committee on Health, Education, Labor & Pensions...
July 26, 2017
PCMA requested that Milliman estimate the value of direct and indirect remuneration (DIR) for Medicare Prescription Drug Plan (PDP) stakeholders....
June 29, 2017
PCMA requested that Milliman estimate the impact of shifting price concessions reflected as DIR to price concessions at the POS...
June 13, 2017
Pharmaceutical Care Management Association Statement for the Record Prepared for the UNITED STATES SENATE COMMITTEE ON HEALTH, EDUCATION, LABOR, and...
Increasing Prices Set by Drug Makers Not Correlated With Rebates
June 09, 2017
As the debate over high drug prices has intensified, drug makers have attempted to shift focus away from the increasing...
PBMs Provide Clinical Value to Patients, Doctors and Other Healthcare Providers
May 01, 2017
Pharmacy Benefit Managers (PBMs) are critical to the delivery of high-quality, cost-effective healthcare. PBMs have long been recognized for their...